AbangeLabsRWE fails when it is treated as a late appendix instead of submission architecture. Canada and EU HTA now reward early evidence planning and traceable decision logic. https://www.mattheneus.com/editorial/rwe-submission-architecture-canada-eu-hta-evidence-planning-playbook-2026-04-01 #HTA #RWE #RegulatoryAffairs #EvidenceSynthesis
Real-world evidence (RWE) is now a submission architecture problem for health technology assessment (HTA) teams, not a late appendix
A new Value in Health Regional Issues environmental scan published online on 31 March 2026 found that 25.5% of Canada's Drug Agency reimbursement submissions from 2020 to mid-2024 already included real-world evidence (RWE), yet reviewers repeatedly challenged data quality, generalisability, and the lack of Canadian data.